Epoch Investment Partners Inc. Sells 120,497 Shares of Encompass Health Corporation $EHC

Epoch Investment Partners Inc. trimmed its stake in Encompass Health Corporation (NYSE:EHC) by 13.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 767,228 shares of the company’s stock after selling 120,497 shares during the quarter. Epoch Investment Partners Inc.’s holdings in Encompass Health were worth $81,434,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. WPG Advisers LLC grew its stake in Encompass Health by 73.3% in the fourth quarter. WPG Advisers LLC now owns 324 shares of the company’s stock valued at $34,000 after purchasing an additional 137 shares in the last quarter. Flagship Harbor Advisors LLC bought a new position in Encompass Health in the fourth quarter valued at approximately $37,000. Assetmark Inc. grew its stake in Encompass Health by 88.1% in the third quarter. Assetmark Inc. now owns 299 shares of the company’s stock valued at $38,000 after purchasing an additional 140 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its stake in Encompass Health by 36,200.0% in the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock valued at $46,000 after purchasing an additional 362 shares in the last quarter. Finally, Covestor Ltd grew its stake in Encompass Health by 24.4% in the fourth quarter. Covestor Ltd now owns 540 shares of the company’s stock valued at $57,000 after purchasing an additional 106 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

EHC has been the subject of a number of recent analyst reports. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Encompass Health in a research report on Monday, June 8th. TD Cowen initiated coverage on Encompass Health in a research report on Thursday, May 28th. They issued a “buy” rating and a $125.00 price objective for the company. Leerink Partners set a $152.00 price objective on Encompass Health in a research report on Friday, May 22nd. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Finally, Barclays cut their price objective on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, May 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $143.86.

Encompass Health Stock Performance

EHC opened at $101.49 on Friday. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99. The stock has a market cap of $10.07 billion, a price-to-earnings ratio of 16.94, a PEG ratio of 2.21 and a beta of 0.72. The business has a 50 day moving average of $104.31 and a 200-day moving average of $104.65. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The business’s revenue was up 9.0% on a year-over-year basis. During the same period last year, the firm posted $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, equities research analysts expect that Encompass Health Corporation will post 5.97 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, July 1st. Encompass Health’s dividend payout ratio (DPR) is presently 12.69%.

Insiders Place Their Bets

In related news, EVP Patrick William Tuer sold 682 shares of Encompass Health stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the completion of the sale, the executive vice president directly owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. This trade represents a 2.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.80% of the company’s stock.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.